Related Experiment Video

Updated: Apr 30, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

Non-MRI biomarkers should be accepted to guide treatment escalation in MS: NO

James M Stankiewicz1

  • 1Novartis Pharmaceutical Corporation, East Hanover, NJ, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 29, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Related Experiment Videos

Last Updated: Apr 30, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

Articles linked to this work by shared authors, journal, and citation graph.

A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.

Neurology. Clinical practice·2025

Affective reserve in older adults with and without multiple sclerosis: A residual-based approach.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Persistent differences in initial diagnostic trajectory for Black and Hispanic individuals presenting with multiple sclerosis between 2020 and 2023.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Taking another look: LBSL diagnosed in adulthood masquerading as multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Implementation of a pilot online educational program to identify paramagnetic rim lesions.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

A facile method for purifying viral immunogens using magnetic beads to generate neutralizing antibodies.

Japanese journal of infectious diseases·2026

Sink or Swim: Making sense of the NICE Intravenous Fluid Guidelines as a Foundation Year Doctor.

Clinical medicine (London, England)·2026

PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.

Journal of hepatocellular carcinoma·2026

Breaking the antimicrobial resistance dilemma: marine natural products, a treasure trove for the development of new anti-Staphylococcus aureus drugs.

Marine life science & technology·2026

Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications.

iScience·2026

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

International journal of pharmaceutics: X·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us